LADENBURG THALMANN FINANCIAL SERVICES INC. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 182 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$178,000
+41.3%
36,094
-17.0%
0.00%0.0%
Q3 2019$126,000
-51.2%
43,467
+19.1%
0.00%
-50.0%
Q2 2019$258,000
-59.8%
36,502
-18.6%
0.00%
-60.0%
Q1 2019$641,000
-4.2%
44,830
-0.6%
0.01%
-16.7%
Q4 2018$669,000
+66800.0%
45,110
+180340.0%
0.01%
Q3 2018$1,000250.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$42,827,4173.52%
TPG GP A, LLC 12,328,767$24,534,2460.48%
CM Management, LLC 150,000$2990.36%
Signature Wealth Management Partners, LLC 87,666$174,4550.17%
Eversept Partners, LP 830,960$1,653,6100.14%
Tranquilli Financial Advisor LLC 71,414$142,1140.11%
Hedges Asset Management LLC 50,000$99,5000.09%
XTX Topco Ltd 191,502$381,0890.08%
EMC Capital Management 40,613$810.07%
Orbimed Advisors 1,583,490$3,151,1450.06%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders